Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aim: To assess the prevalence of individual obesity-related complications (ORCs) and multimorbidity (≥ 1, ≥ 2 and ≥ 3 ORCs), and multimorbidity-associated healthcare costs, over 10 years.

Methods: This retrospective open cohort study used Discover, a UK database of linked primary and secondary electronic health records. Adults were stratified by body mass index (BMI; overweight: 25-< 30 kg/m; obesity class I: 30-< 35 kg/m; obesity class II: 35-< 40 kg/m; obesity class III: ≥ 40 kg/m). Outcomes by year since baseline were assessed for serial cross sections across the study period (1 January 2004 to 31 December 2019; the index date was the date of first eligible BMI measurement).

Results: Across 1 410 146 individuals (overweight: 1 008 101; obesity class I: 278 782; obesity class II: 80 621; obesity class III: 42 642), ORC prevalence was higher in successive BMI groups, and increases over time were generally greater for obesity relative to overweight. In those with ORC multimorbidity, both higher BMI and the presence of more ORCs were associated with higher annual per-person healthcare costs. Costs increased over time in those individuals with obesity and one or more ORC, as well as in those with obesity and two or more ORCs.

Conclusions: Higher BMI was associated with higher baseline ORC prevalence and a greater increase in ORC prevalence over time, and with higher healthcare costs in those with multimorbidity. To reduce the burden of overweight and obesity on patients and healthcare systems, the presence, number and type of ORCs should be considered in developing effective, targeted prevention and management care pathways.

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.15836DOI Listing

Publication Analysis

Top Keywords

obesity-related complications
8
retrospective open
8
open cohort
8
cohort study
8
ten-year progression
4
progression obesity-related
4
complications population
4
population overweight
4
overweight obesity
4
obesity retrospective
4

Similar Publications

Mendelian randomization studies on cardiometabolic factors and intracranial aneurysms: A systematic literature analysis.

Zhong Nan Da Xue Xue Bao Yi Xue Ban

May 2025

Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha 410013, China.

Objectives: Intracranial aneurysm (IA) has an insidious onset, and once ruptured, it carries high rates of mortality and disability. Cardiometabolic factors may be associated with the formation and rupture of IA. This study aims to summarize the application of Mendelian randomization (MR) methods in research on cardiometabolic factors and IA, providing insights for further elucidation of IA etiology and pathogenesis.

View Article and Find Full Text PDF

Overweight and obesity represent common chronic metabolic disorders in the general population, and observed trends describe a substantial growth in the prevalence of weight excess also among individuals with type 1 diabetes (T1D), the so-called 'lean phenotype' of diabetes. The sharp rise of weight excess and obesity-related cardio-nephron-metabolic burdens observed in T2D is expected to produce similar consequences in T1D, leading to the urgent need to endorse therapeutic protocols as in most parts of the World no adjunctive treatments are approved for T1D, making weight excess management challenging in these individuals. The notable results shown by newer glucagon-like peptide 1 receptor agonists (GLP-1RAs) and emerging dual agonists, especially while managing cardio-metabolic burdens, in T2D have encouraged fervent anecdotal and non-anecdotal research also in T1D, indicating that non-insulin injective agents can be effective and safe.

View Article and Find Full Text PDF

Obesity-related complications are often driven by chronic inflammation and oxidative stress, exacerbated by aberrant DNA methylation. Natural products with anti-inflammatory and antioxidant properties may offer therapeutic potential. This study investigated the potential molecular mechanisms underlying the effects of Tratt fermentation broth (RRTFB) on obesity through targeted methylation, while also examining its primary active components and assessing its potential therapeutic value.

View Article and Find Full Text PDF

From obesity to comorbidities: A comprehensive care approach for improved health by the Spanish Society of Internal Medicine.

Rev Clin Esp (Barc)

September 2025

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain; Catedrático de Medicina, Universidad de Córdoba, Córdoba, Spain; Servicio de Medicina Interna, Hospital Universitario Reina Sofía, Córdoba.

Obesity is currently recognized as a chronic, progressive, and relapsing disease, and constitutes a major global public health challenge. This document, promoted by the Spanish Society of Internal Medicine through its Working Group on Diabetes, Obesity, and Nutrition, outlines a comprehensive, multidisciplinary approach to care, with a specific focus on obesity-related comorbidities. Excess adipose tissue is conceptualized as a systemic pathogenic agent that actively contributes to the pathophysiology of numerous complications, including cardiovascular disease, heart failure, chronic kidney disease, osteoarthritis, obstructive sleep apnea, and metabolic dysfunction-associated steatotic liver disease (MASLD).

View Article and Find Full Text PDF

To investigate the changes in self-reported outcomes and body composition among colorectal cancer (CRC) patients over the course of chemotherapy and differences in body composition among different self-reported trajectory subgroups. Prospective longitudinal study. This longitudinal study surveyed 201 CRC patients from a cancer hospital in Fuzhou, China.

View Article and Find Full Text PDF